Burning Rock Biotech vs Fulgent Genetics
BNR and FLGT side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BNR and FLGT compare
Fulgent Genetics grew revenue faster over the last twelve months (4.7% versus 4.6% for Burning Rock Biotech).
Burning Rock Biotech keeps more of each dollar of sales as profit, with a net margin of −10.3% compared with −27.5% at Fulgent Genetics.
Fulgent Genetics scores higher on the StockData Score (8 against 5 for Burning Rock Biotech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BNR | FLGT |
|---|---|---|
| Size and price | ||
| Market cap | – | $679M |
| Share price | $13.29 | $24.66 |
| Change, 1 year | 8.8% | −15.2% |
| Change, 5 years | −92.2% | −73.8% |
| Beta (5Y) | 1.73 | 0.89 |
| Employees | 667 | 1,300 |
| StockData Score | ||
| Total score | 5 | 8 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 2.1× |
| P/B | – | 0.7× |
| FCF yield | – | −0.21% |
| Fair value | – | $46.08 |
| Margin of safety | – | 46.5% |
| Growth | ||
| Revenue growth (TTM) | 4.6% | 4.7% (better) |
| Revenue growth, 5Y average | 4.6% (better) | −5.2% |
| Profitability | ||
| Gross margin | 74.7% (better) | 33.8% |
| Operating margin | −10.2% (better) | −39.2% |
| Net margin | −10.3% (better) | −27.5% |
| FCF margin | −6.2% | −0.42% (better) |
| Return on equity | −9.9% | −8.6% (better) |
| Return on invested capital | −72.5% | −12.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 (better) |
| Interest coverage | – | −1307.9× |
| Current ratio | 2.99 | 5.34 (better) |
| Altman Z-score | – | 5.18 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 9.5% |
| Shareholder yield | – | 9.5% |
| Ownership | ||
| Held by institutions | 1.8% | 57.0% |
| Held by insiders | 19.0% | 39.5% |
| Insider net buying, 12 months | $11.6M (better) | −$286K |
| Short interest, % of float | – | 12.1% |
Go deeper
- BNR stock overview
- BNR income statement
- BNR valuation and score
- FLGT stock overview
- FLGT income statement
- FLGT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.